Research Brief: Kaplan Study

Provider-Payer Collaboration Reduces Panic Disorder Costs

Evaluating the Impact of Freespira on Panic Disorder Patients’ Health Outcomes and Healthcare Costs within the Allegheny Health Network

Panic Disorder Patients Cost Up to 5x More

Panic disorder is a debilitating condition that can significantly impair a patient’s social and occupational functioning, as well as their quality of life. It also leads to use of health care services at a rate five times that of matched control patients and twice the cost of individuals with other chronic conditions such as diabetes or asthma, according to a study conducted by the Blue Cross Blue Shield insurer Highmark Health.

05437 Rev A

Download Research Brief